Ceva support to the 11th IFCN Dairy Conference >
This year for the 11th time, leading dairy related companies came together at the IFCN Supporter Conference, held September 16th to 18th 2012 in Oxford, UK. IFCN stands for International Farm Comparison Network. This researcher’s organization provides the latest global information on milk production and the overall sector developments.
Ceva stresses the need for more INNOVATION in the hatchery to drive growing global demand for poultry meat >
Company launches Cevac IBird ® a live, attenuated IB vaccine, to add to its portfolio of 16 new technology vaccines
Ceva launches new Vectormune ® website >
Website provides educational resources for poultry professionals, as well as comprehensive information about their vector vaccines range.
Ceva stresses the need for more INNOVATION in the hatchery to drive growing global demand for poultry meat >
Company launches Cevac IBird ® a live, attenuated IB vaccine, to add to its portfolio of 16 new technology vaccines
Ceva will be at the 18th World’s Poultry Congress >
Congress Center, Nantes Events Center «La Cité»
Ceva’s growth continues despite difficult market conditions >
Libourne, France, 22 July, 2013: Consolidated sales of the Ceva Group reached €310m in the first 6 months of 2013, up by 2%, 4.2% on the previous year at a constant perimeter and exchange rates. Ceva recorded solid growth of 9% on a constant basis (constant perimeter and exchange rates), if one excludes 2 factors: Vectra® sales in the United States, which were less than anticipated, due to a...
Ceva signs a Joint-venture agreement in China to help control zoonoses >
Joint-venture with Jinyu Baoling will produce brucellosis vaccines in Inner Mongolia
Signature of a scientific collaboration protocol about avian influenza with South China Agricultural University >
Paris, May 29th 2013 1- Ceva, a socially responsible company committed to the well-being of the planet Ceva Santé Animale is a multi-national French based animal health company that counts over 3000 employees, 800 of whom are based in France, with a turnover which exceeds 600 M€. The company was formed in 1999, when Sanofi sold its veterinary business. Since then, Ceva has seen constant and spectacular...
2013 reprodAction Scientific Meeting - April 16-17th >
“Management and reproduction of dairy heifers”
Ceva uses creative thinking in new approach to innovation in Industrial equity >
Libourne, France 2nd May 2013: Most of the time innovation in the bio-pharmaceutical field is associated with the scientific R&D teams. But having the latest technology vaccines is of little value if you cannot produce them efficiently, on time and to the highest quality standards. As a result, Ceva recently organized its first industrial innovation day – entitled Together, Creative Innovation,...